Boston Scientific (NYSE:BSX) has agreed to settle a transvaginal mesh class action lawsuit brought by women in Canada for $21.5 million, according to a report by the Canadian Press. The proposed settlement involves about 325 women whose share of the money would depend on the severity of their medical issues, the news service reported. Final approval […]
BREAKING: J&J ordered to pay $344m in California pelvic mesh case
A California judge ruled today that Johnson & Johnson and its Ethicon subsidiary must pay $344 million in penalties in a case claiming false and deceptive marketing of its pelvic mesh products for women. The California Department of Justice said it sued Johnson & Johnson in May 2016 after a years-long multistate investigation revealed the […]
Court tosses J&J’s appeal in $20 million pelvic mesh case
This article has been updated with a comment from Ethicon. An Indiana federal appeals court yesterday upheld a $20 million jury award in a pelvic mesh case against Johnson & Johnson’s (NYSE:JNJ) Ethicon unit. Despite the “flurry of arguments” in its appeal, the company failed to convince the three-judge panel that it should overturn the […]
J&J’s Ethicon defeats all but 4 claims in Kentucky pelvic mesh case
A federal judge in Kentucky has dismissed all but four claims in a pelvic mesh lawsuit against Johnson & Johnson’s (NYSE:JNJ) Ethicon division. Jensesta Cutter had Ethicon’s Prolift pelvic mesh implanted in 2006 and complained to her doctor that year of pelvic pain, soreness and burning, constipation and urine leakage, according to the complaint. In […]
Johnson & Johnson agrees to $117m pelvic mesh settlement with 41 states, DC
Johnson & Johnson (NYSE:JNJ) yesterday agreed to pay $117 million to settle charges of deceptive marketing of its pelvic mesh products with 41 states and the District of Columbia. The states and DC alleged that J&J and subsidiary Ethicon broke state consumer protection laws by misrepresenting the safety and effectiveness of its mesh devices, which […]
West Virginia AG sues Johnson & Johnson over pelvic mesh
West Virginia attorney general Patrick Morrisey yesterday became the latest state AG to sue Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon over its pelvic mesh products. The newest complaint, filed Sept. 18 in the Monongalia County Circuit Court, alleges that Ethicon’s “unlawful, unfair and deceptive marketing of polypropylene mesh products” concealed the potential risks of pelvic […]
First state AG suit over pelvic mesh heads to trial
The first lawsuit filed by a state attorney general, California’s Xavier Becerra, over pelvic mesh products went to trial yesterday in San Diego. The lawsuit alleges that Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon concealed the potential risks of pelvic mesh from the public and physicians. It’s the first of several lawsuits brought by state AGs […]
Johnson & Johnson unit loses 9th pelvic mesh case in Philly
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon last week reportedly lost the ninth of eleven product liability lawsuits brought before a Pennsylvania state court when the jury awarded $500,000 in damages to the plaintiff. In handing down the July 28 verdict for Linda Dunfee and her husband Thomas Dunfee, the jury in the Philadelphia County Court […]
Investor lodges class action suit against Boston Scientific over U.S. mesh withdrawal
A plaintiff purporting to represent Boston Scientific shareholders sued the company yesterday, alleging that it misled investors about the prospects for its pelvic mesh products ahead of an FDA order to halt all U.S. sales of the devices. Last week the FDA ordered an immediate halt to sales and distribution of Boston’s Uphold Lite and Xenform products; […]
Plaintiff wins $120m in latest pelvic mesh trial against Johnson & Johnson unit
A state court jury in Philadelphia reportedly slapped Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon with a $120 million verdict yesterday in a product liability lawsuit brought over one of its pelvic mesh products. The jury in the Pennsylvania Court of Common pleas awarded Susan McFarland $20 million in compensatory damages and $100 million in punitive damages after […]
FDA’s pelvic mesh ban spooks investors
The FDA’s ban on U.S. sales of pelvic mesh products for pelvic organ prolapse may have spooked investors, but should only have a minimal effect on the books at Boston Scientific (NYSE:BSX) and Coloplast (CPH:COLO-B) – the only companies still selling mesh for prolapse in the U.S. – according to analysts and the company. Yesterday the […]
- 1
- 2
- 3
- …
- 10
- Next Page »
